FABP1 and acute kidney injury: Altogether, these results lead us to speculate that IL-17, sCD163, IL-6, and LDH levels during ICIs treatment may serve as predictive markers for irAEs and evaluated in combination with other urinary markers of AKI (commonly KIM-1, L-FABP, IGFBP7, IL-18) could provide additional information also for the risk of ICIs-induced AKI.